Enhancing Prospective Thinking in Early Recovery (HOME)

Официальное название

Enhancing Prospective Thinking in Early Recovery

Обзор

The goal of this clinical trial is to use a novel virtual reality intervention to test for efficacy in reducing alcohol use and increasing abstinence, with concomitant increases in future self-identification, future time perspective, and delay-of-reward, in early recovering alcohol use disorder (AUD) persons. The main question\[s\] this trial aims to answer are: Will the Virtual Reality (VR) intervention decrease the number of stimulant use days? Will the VR intervention produce longer abstinence periods during follow-up visits? Will the VR intervention increase alcohol abstinence rates? Will the VR intervention increase future self-identification? Will the VR intervention increase self-reported future time perspective? Will the VR intervention increase preference for delayed rewards in a laboratory delay discounting task on the study day? Will the VR intervention produce gains in the behavioral effects of future self-identification, future time perspective, and delayed rewards at the 30-day and 6-month follow-ups? Researchers will compare the experimental and control groups to see if there are differences in the results for the questions outlined above.

Вмешательства

• Устройство Virtual Reality
  They will receive a Virtual Reality Park experience, which is an empty park with no avatars. They will then have a Virtual Reality Avatar experience, where they will see an avatar resembling themselves in a park setting.
• Устройство Virtual Reality
  They will receive a Virtual Reality Park experience, which is an empty park with no avatars.

Первичные конечные точки

• Reduced Use of Drug Using Days [Срок оценки: Day 2-Study Day Visit; 30-day Follow-up Visit; 6-month Follow-up Visit]
• Increased Length of Abstinence [Срок оценки: Day 2-Study Day Visit; 30-day Follow-up Visit; 6-month Follow-up Visit.]
• Increased (overall) Abstinence [Срок оценки: Day 2-Study Day Visit; 30-day Follow-up Visit; 6-month Follow-up Visit.]
• Future Self-identification with Future Self Continuity Questionnaire [Срок оценки: Day 2-Study Day Visit; 30-day Follow-up Visit; 6-month Follow-up Visit]
• Future Time Perspective with the Delayed Discounting Behavioral Task and Future Self Continuity Questionnaire [Срок оценки: Day 2-Study Day Visit; 30-day Follow-up Visit; 6-month Follow-up Visit.]
• Delayed Reward Preference with the Delayed Discounting Behavioral Task [Срок оценки: Day 2-Study Day Visit; 30-day Follow-up Visit; 6-month Follow-up Visit.]

Критерии участия

Критерии включения

• Abstinence between ≥14 days and ≤1 year
• Verbal endorsement of commitment to recovery
• Outpatient
• Psychotropic drugs for SUD-comorbidity
• Drug/alcohol abstinence ≥ 24 hours at the time of the study day visit
• English comprehension

Критерии исключения

• Unstable medical disorders
• Habitual drug use
• Mu-opioid drugs
• Smell/taste disorders
• Unstable psychiatric conditions
• Extravagant/elaborate face tattoos

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Распределение

Рандомизированное

Модель

Параллельные группы

Маскирование

Простое слепое

Основная цель

Фундаментальное исследование

Центры проведения

США · 1 центр

• Indiana University School of Medicine - Goodman Hal — Indianapolis

Идентификаторы

NCT: NCT06302413 · 1805574553; Aims 9-10 · 1R01AA029396-01

Первоисточники (государственные реестры)

• ClinicalTrials.gov (NIH, США)

Открыть это исследование на ClinicalTrials.gov ↗